ID
13709
Beschrijving
Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00742625
Link
https://clinicaltrials.gov/show/NCT00742625
Trefwoorden
Versies (1)
- 29-02-16 29-02-16 -
Houder van rechten
CC BY-NC 3.0
Geüploaded op
29 februari 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Acute Myeloid Leukemia NCT00742625
Eligibility Acute Myeloid Leukemia NCT00742625
- StudyEvent: Eligibility
Similar models
Eligibility Acute Myeloid Leukemia NCT00742625
- StudyEvent: Eligibility
C0332152 (UMLS CUI [1,2])
C3463824 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C0006147 (UMLS CUI [2])
C0010266 (UMLS CUI [2])
C0031117 (UMLS CUI [3])
C1514463 (UMLS CUI [1,2])
C0023416 (UMLS CUI [2,1])
C0013956 (UMLS CUI [2,2])
C3805210 (UMLS CUI [3])
C0013956 (UMLS CUI [4,1])
C0020402 (UMLS CUI [4,2])
C0282548 (UMLS CUI [5,1])
C1269563 (UMLS CUI [5,2])
C1522449 (UMLS CUI [6,1])
C3163632 (UMLS CUI [6,2])
C0018284 (UMLS CUI [7])
C0199974 (UMLS CUI [8])
C0205420 (UMLS CUI [1,2])
C0038317 (UMLS CUI [2])
C0001623 (UMLS CUI [3])
C0020517 (UMLS CUI [4])
C0036983 (UMLS CUI [5])
C0279025 (UMLS CUI [6,1])
C1546988 (UMLS CUI [6,2])
C0012634 (UMLS CUI [6,3])